Epidemiology of multiple sclerosis
Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and Europe (>100/100,000 inhabitants) to low rates in Eastern Asia and sub-Saharan Africa (2/100,000 population). Knowledge of the geographical...
Saved in:
| Published in: | Revue neurologique Vol. 172; no. 1; pp. 3 - 13 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
France
Elsevier Masson SAS
01.01.2016
Elsevier Masson |
| Subjects: | |
| ISSN: | 0035-3787 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and Europe (>100/100,000 inhabitants) to low rates in Eastern Asia and sub-Saharan Africa (2/100,000 population). Knowledge of the geographical distribution of the disease and its survival data, and a better understanding of the natural history of the disease, have improved our understanding of the respective roles of endogenous and exogenous causes of MS. Concerning mortality, in a large French cohort of 27,603 patients, there was no difference between MS patients and controls in the first 20 years of the disease, although life expectancy was reduced by 6–7 years in MS patients. In 2004, the prevalence of MS in France was 94.7/100,000 population, according to data from the French National Health Insurance Agency for Salaried Workers (Caisse nationale d’assurance maladie des travailleurs Salariés [CNAM-TS]), which insures 87% of the French population. This prevalence was higher in the North and East of France. In several countries, including France, the gender ratio for MS incidence (women/men) went from 2/1 to 3/1 from the 1950s to the 2000s, but only for the relapsing–remitting form. As for risk factors of MS, the most pertinent environmental factors are infection with Epstein-Barr virus (EBV), especially if it arises after childhood and is symptomatic. The role of smoking in MS risk has been confirmed, but is modest. In contrast, vaccines, stress, traumatic events and allergies have not been identified as risk factors, while the involvement of vitamin D has yet to be confirmed. From a genetic point of view, the association between HLA-DRB1*15:01 and a high risk of MS has been known for decades. More recently, immunogenetic markers have been identified (IL2RA, IL7RA) and, in particular thanks to studies of genome-wide associations, more than 100 genetic variants have been reported. Most of these are involved in the immune response and often associated with other autoimmune diseases. Studies of the natural history of MS suggest it is a two-phase disease: in the first phase, inflammation is focal with flares; and in the second phase, disability progresses independently of focal inflammation. This has clear implications for therapy. Age may also be a key factor in the phenotype of the disease. In conclusion, France is a high-risk country for MS, but it only slightly reduces life expectancy. MS is a multifactorial disease and the implications of immunogenetics are major. Preventative approaches might be derived from knowledge of the risk factors and natural history of the disease (smoking, vitamin D). |
|---|---|
| AbstractList | Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and Europe (>100/100,000 inhabitants) to low rates in Eastern Asia and sub-Saharan Africa (2/100,000 population). Knowledge of the geographical distribution of the disease and its survival data, and a better understanding of the natural history of the disease, have improved our understanding of the respective roles of endogenous and exogenous causes of MS. Concerning mortality, in a large French cohort of 27,603 patients, there was no difference between MS patients and controls in the first 20 years of the disease, although life expectancy was reduced by 6-7 years in MS patients. In 2004, the prevalence of MS in France was 94.7/100,000 population, according to data from the French National Health Insurance Agency for Salaried Workers (Caisse nationale d'assurance maladie des travailleurs Salariés [CNAM-TS]), which insures 87% of the French population. This prevalence was higher in the North and East of France. In several countries, including France, the gender ratio for MS incidence (women/men) went from 2/1 to 3/1 from the 1950s to the 2000s, but only for the relapsing-remitting form. As for risk factors of MS, the most pertinent environmental factors are infection with Epstein-Barr virus (EBV), especially if it arises after childhood and is symptomatic. The role of smoking in MS risk has been confirmed, but is modest. In contrast, vaccines, stress, traumatic events and allergies have not been identified as risk factors, while the involvement of vitamin D has yet to be confirmed. From a genetic point of view, the association between HLA-DRB1*15:01 and a high risk of MS has been known for decades. More recently, immunogenetic markers have been identified (IL2RA, IL7RA) and, in particular thanks to studies of genome-wide associations, more than 100 genetic variants have been reported. Most of these are involved in the immune response and often associated with other autoimmune diseases. Studies of the natural history of MS suggest it is a two-phase disease: in the first phase, inflammation is focal with flares; and in the second phase, disability progresses independently of focal inflammation. This has clear implications for therapy. Age may also be a key factor in the phenotype of the disease. In conclusion, France is a high-risk country for MS, but it only slightly reduces life expectancy. MS is a multifactorial disease and the implications of immunogenetics are major. Preventative approaches might be derived from knowledge of the risk factors and natural history of the disease (smoking, vitamin D).Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and Europe (>100/100,000 inhabitants) to low rates in Eastern Asia and sub-Saharan Africa (2/100,000 population). Knowledge of the geographical distribution of the disease and its survival data, and a better understanding of the natural history of the disease, have improved our understanding of the respective roles of endogenous and exogenous causes of MS. Concerning mortality, in a large French cohort of 27,603 patients, there was no difference between MS patients and controls in the first 20 years of the disease, although life expectancy was reduced by 6-7 years in MS patients. In 2004, the prevalence of MS in France was 94.7/100,000 population, according to data from the French National Health Insurance Agency for Salaried Workers (Caisse nationale d'assurance maladie des travailleurs Salariés [CNAM-TS]), which insures 87% of the French population. This prevalence was higher in the North and East of France. In several countries, including France, the gender ratio for MS incidence (women/men) went from 2/1 to 3/1 from the 1950s to the 2000s, but only for the relapsing-remitting form. As for risk factors of MS, the most pertinent environmental factors are infection with Epstein-Barr virus (EBV), especially if it arises after childhood and is symptomatic. The role of smoking in MS risk has been confirmed, but is modest. In contrast, vaccines, stress, traumatic events and allergies have not been identified as risk factors, while the involvement of vitamin D has yet to be confirmed. From a genetic point of view, the association between HLA-DRB1*15:01 and a high risk of MS has been known for decades. More recently, immunogenetic markers have been identified (IL2RA, IL7RA) and, in particular thanks to studies of genome-wide associations, more than 100 genetic variants have been reported. Most of these are involved in the immune response and often associated with other autoimmune diseases. Studies of the natural history of MS suggest it is a two-phase disease: in the first phase, inflammation is focal with flares; and in the second phase, disability progresses independently of focal inflammation. This has clear implications for therapy. Age may also be a key factor in the phenotype of the disease. In conclusion, France is a high-risk country for MS, but it only slightly reduces life expectancy. MS is a multifactorial disease and the implications of immunogenetics are major. Preventative approaches might be derived from knowledge of the risk factors and natural history of the disease (smoking, vitamin D). Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and Europe (>100/100,000 inhabitants) to low rates in Eastern Asia and sub-Saharan Africa (2/100,000 population). Knowledge of the geographical distribution of the disease and its survival data, and a better understanding of the natural history of the disease, have improved our understanding of the respective roles of endogenous and exogenous causes of MS. Concerning mortality, in a large French cohort of 27,603 patients, there was no difference between MS patients and controls in the first 20 years of the disease, although life expectancy was reduced by 6–7 years in MS patients. In 2004, the prevalence of MS in France was 94.7/100,000 population, according to data from the French National Health Insurance Agency for Salaried Workers (Caisse nationale d’assurance maladie des travailleurs Salariés [CNAM-TS]), which insures 87% of the French population. This prevalence was higher in the North and East of France. In several countries, including France, the gender ratio for MS incidence (women/men) went from 2/1 to 3/1 from the 1950s to the 2000s, but only for the relapsing–remitting form. As for risk factors of MS, the most pertinent environmental factors are infection with Epstein-Barr virus (EBV), especially if it arises after childhood and is symptomatic. The role of smoking in MS risk has been confirmed, but is modest. In contrast, vaccines, stress, traumatic events and allergies have not been identified as risk factors, while the involvement of vitamin D has yet to be confirmed. From a genetic point of view, the association between HLA-DRB1*15:01 and a high risk of MS has been known for decades. More recently, immunogenetic markers have been identified (IL2RA, IL7RA) and, in particular thanks to studies of genome-wide associations, more than 100 genetic variants have been reported. Most of these are involved in the immune response and often associated with other autoimmune diseases. Studies of the natural history of MS suggest it is a two-phase disease: in the first phase, inflammation is focal with flares; and in the second phase, disability progresses independently of focal inflammation. This has clear implications for therapy. Age may also be a key factor in the phenotype of the disease. In conclusion, France is a high-risk country for MS, but it only slightly reduces life expectancy. MS is a multifactorial disease and the implications of immunogenetics are major. Preventative approaches might be derived from knowledge of the risk factors and natural history of the disease (smoking, vitamin D). Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and Europe (>100/100,000 inhabitants) to low rates in Eastern Asia and sub-Saharan Africa (2/100,000 population). Knowledge of the geographical distribution of the disease and its survival data, and a better understanding of the natural history of the disease, have improved our understanding of the respective roles of endogenous and exogenous causes of MS. Concerning mortality, in a large French cohort of 27,603 patients, there was no difference between MS patients and controls in the first 20 years of the disease, although life expectancy was reduced by 6-7 years in MS patients. In 2004, the prevalence of MS in France was 94.7/100,000 population, according to data from the French National Health Insurance Agency for Salaried Workers (Caisse nationale d'assurance maladie des travailleurs Salariés [CNAM-TS]), which insures 87% of the French population. This prevalence was higher in the North and East of France. In several countries, including France, the gender ratio for MS incidence (women/men) went from 2/1 to 3/1 from the 1950s to the 2000s, but only for the relapsing-remitting form. As for risk factors of MS, the most pertinent environmental factors are infection with Epstein-Barr virus (EBV), especially if it arises after childhood and is symptomatic. The role of smoking in MS risk has been confirmed, but is modest. In contrast, vaccines, stress, traumatic events and allergies have not been identified as risk factors, while the involvement of vitamin D has yet to be confirmed. From a genetic point of view, the association between HLA-DRB1*15:01 and a high risk of MS has been known for decades. More recently, immunogenetic markers have been identified (IL2RA, IL7RA) and, in particular thanks to studies of genome-wide associations, more than 100 genetic variants have been reported. Most of these are involved in the immune response and often associated with other autoimmune diseases. Studies of the natural history of MS suggest it is a two-phase disease: in the first phase, inflammation is focal with flares; and in the second phase, disability progresses independently of focal inflammation. This has clear implications for therapy. Age may also be a key factor in the phenotype of the disease. In conclusion, France is a high-risk country for MS, but it only slightly reduces life expectancy. MS is a multifactorial disease and the implications of immunogenetics are major. Preventative approaches might be derived from knowledge of the risk factors and natural history of the disease (smoking, vitamin D). |
| Author | Fromont, A. Moreau, T. Leray, E. Edan, G. |
| Author_xml | – sequence: 1 givenname: E. surname: Leray fullname: Leray, E. organization: Biostatistics and Epidemiology Department, EHESP, avenue du Professeur-Léon-Bernard, 35000 Rennes, France – sequence: 2 givenname: T. surname: Moreau fullname: Moreau, T. email: thibault.moreau@chu-dijon.fr organization: Neurology Department, EA 4184, University Hospital of Dijon, 14, rue Gaffarel, 21000 Dijon, France – sequence: 3 givenname: A. surname: Fromont fullname: Fromont, A. organization: Neurology Department, EA 4184, University Hospital of Dijon, 14, rue Gaffarel, 21000 Dijon, France – sequence: 4 givenname: G. surname: Edan fullname: Edan, G. organization: Neurology Department, University Hospital of Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes, France |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26718593$$D View this record in MEDLINE/PubMed https://univ-rennes.hal.science/hal-01255824$$DView record in HAL |
| BookMark | eNqFkEtLxDAUhbMYcXz9A5HBlS6m5tE0qQthGHzBgBtdhzS51QxpMyat4L-3Q0cXLnR14fCdA_c7RJM2tIDQKcEZwaS4Wmct9DH4jGLChyjDuJigA4wZnzMhxRQdprTGmBKB2T6a0kIQyUt2gM5vN85C44IPr5-zUM-a3ndu42GWjIcYkkvHaK_WPsHJ7h6hl7vb5-XDfPV0_7hcrOaGlUU3r21JbVlTbSXVklOTl3mtRWkoFRK04JrjWlpgha14RSipgVMpKmlkiSVQdoQux9037dUmukbHTxW0Uw-LldpmmFDOJc0_yMBejOwmhvceUqcalwx4r1sIfVJEFFiWDLN8QM92aF81YH-Wvx0MQD4CZng3Rah_EILVVq9aq1Gv2urdpoPeoXb9q2ZcpzsX2i5q5_8r34xlGIR-OIgqGQetAesimE7Z4P4e-AJVj5hC |
| CitedBy_id | crossref_primary_10_1016_j_msard_2023_105029 crossref_primary_10_3390_medicina60030386 crossref_primary_10_1007_s11481_021_10004_9 crossref_primary_10_3389_fimmu_2022_1010605 crossref_primary_10_1016_j_bbii_2024_100082 crossref_primary_10_2217_nmt_2019_0024 crossref_primary_10_1016_j_msard_2018_05_015 crossref_primary_10_1016_j_compbiomed_2021_104697 crossref_primary_10_1111_ane_13344 crossref_primary_10_1155_2023_6754178 crossref_primary_10_3390_ijms22179290 crossref_primary_10_1016_j_msard_2022_104208 crossref_primary_10_26641_2307_0404_2020_2_206348 crossref_primary_10_1016_j_msard_2018_08_004 crossref_primary_10_1016_j_lfs_2021_119343 crossref_primary_10_1111_cts_13794 crossref_primary_10_3390_biom14080926 crossref_primary_10_1016_j_jneuroim_2017_02_015 crossref_primary_10_1016_j_msard_2023_104626 crossref_primary_10_1002_bkcs_11370 crossref_primary_10_1136_bmjopen_2021_049580 crossref_primary_10_3389_fphar_2021_698133 crossref_primary_10_1016_j_jbiotec_2020_03_013 crossref_primary_10_7759_cureus_24895 crossref_primary_10_1016_j_neurol_2025_06_009 crossref_primary_10_2174_0929867329666220615124412 crossref_primary_10_1080_00207454_2020_1860964 crossref_primary_10_1016_j_msard_2020_102264 crossref_primary_10_1016_j_msard_2019_07_030 crossref_primary_10_1055_s_0043_1771001 crossref_primary_10_1016_j_msard_2024_106183 crossref_primary_10_1186_s12883_022_02820_0 crossref_primary_10_1155_2020_3582947 crossref_primary_10_1016_j_ailsci_2022_100042 crossref_primary_10_1016_j_msard_2018_09_018 crossref_primary_10_1002_acn3_51649 crossref_primary_10_1016_j_brainresbull_2020_06_013 crossref_primary_10_1177_20584601221105228 crossref_primary_10_1016_j_jns_2020_116768 crossref_primary_10_1098_rsos_241052 crossref_primary_10_3390_tropicalmed6030170 crossref_primary_10_1016_j_msard_2023_104962 crossref_primary_10_1177_18758894251329690 crossref_primary_10_1007_s11065_024_09640_8 crossref_primary_10_3389_fneur_2021_678245 crossref_primary_10_3389_fneur_2025_1513390 crossref_primary_10_1088_1748_605X_abddf4 crossref_primary_10_1093_arclin_acw089 crossref_primary_10_1007_s40264_018_0652_4 crossref_primary_10_1136_bmjopen_2021_058948 crossref_primary_10_1080_09638288_2018_1461937 crossref_primary_10_3233_TRD_230064 crossref_primary_10_1080_19371918_2020_1810839 crossref_primary_10_1016_j_conctc_2023_101101 crossref_primary_10_1016_j_jmpt_2018_12_010 crossref_primary_10_1016_j_msard_2023_104604 crossref_primary_10_1007_s40801_023_00384_0 crossref_primary_10_1097_QAD_0000000000001603 crossref_primary_10_1007_s40264_017_0551_0 crossref_primary_10_1007_s00115_024_01621_9 crossref_primary_10_1007_s00415_017_8505_0 crossref_primary_10_1071_AH21056 crossref_primary_10_1002_pds_70112 crossref_primary_10_1016_j_msard_2019_101396 crossref_primary_10_3389_fgene_2021_638236 crossref_primary_10_1038_s41531_023_00535_8 crossref_primary_10_1089_omi_2018_0088 crossref_primary_10_1016_j_neurot_2025_e00539 crossref_primary_10_1016_j_jns_2020_117066 crossref_primary_10_1016_j_autrev_2025_103779 crossref_primary_10_1371_journal_pone_0267245 crossref_primary_10_1007_s11517_020_02141_9 crossref_primary_10_1016_j_msard_2017_12_015 crossref_primary_10_3389_fnins_2021_742065 crossref_primary_10_1016_j_msard_2022_103840 crossref_primary_10_1371_journal_pone_0272156 crossref_primary_10_1186_s12883_025_04172_x crossref_primary_10_1515_tnsci_2022_0249 crossref_primary_10_1159_000538221 crossref_primary_10_3390_pathophysiology30010003 crossref_primary_10_1097_MPG_0000000000002654 crossref_primary_10_1080_17686733_2020_1793283 crossref_primary_10_3389_fimmu_2022_805657 crossref_primary_10_1111_joa_70046 crossref_primary_10_1016_j_ejpb_2020_01_005 crossref_primary_10_1080_10400435_2019_1634660 crossref_primary_10_3390_cells11091578 crossref_primary_10_1007_s43630_024_00668_6 crossref_primary_10_3390_neurolint12030016 crossref_primary_10_1177_1352458520985118 crossref_primary_10_1212_WNL_0000000000209885 crossref_primary_10_61882_shefa_13_3_12 crossref_primary_10_1186_s12883_021_02431_1 crossref_primary_10_1016_j_msard_2022_104122 crossref_primary_10_1136_bmjopen_2024_088924 crossref_primary_10_1371_journal_pone_0307455 crossref_primary_10_4103_ijoy_ijoy_270_24 crossref_primary_10_1016_j_bspc_2019_101696 crossref_primary_10_1080_14737175_2017_1245616 crossref_primary_10_1016_j_msard_2025_106727 crossref_primary_10_1038_s41598_023_41271_6 crossref_primary_10_3389_fneur_2019_00781 crossref_primary_10_3390_pharmaceutics15051369 crossref_primary_10_3390_medicina58030414 crossref_primary_10_1007_s10792_024_03217_3 crossref_primary_10_1007_s40263_024_01072_5 crossref_primary_10_1007_s00415_024_12331_2 crossref_primary_10_3390_brainsci12060800 crossref_primary_10_3390_ijerph19159452 crossref_primary_10_3389_fneur_2024_1348778 crossref_primary_10_3390_ijms24108827 crossref_primary_10_7717_peerj_16465 crossref_primary_10_1111_ijun_12341 crossref_primary_10_1007_s12640_021_00361_x crossref_primary_10_1186_s12883_020_01882_2 crossref_primary_10_7759_cureus_10825 crossref_primary_10_7717_peerj_8812 crossref_primary_10_3390_jcm13216315 crossref_primary_10_1186_s41983_023_00702_x crossref_primary_10_1016_j_neuint_2019_104516 crossref_primary_10_1016_j_msard_2022_104109 crossref_primary_10_1186_s12883_022_02606_4 crossref_primary_10_1186_s12864_024_10183_8 crossref_primary_10_1016_j_cyto_2018_03_039 crossref_primary_10_1080_1744666X_2022_2117160 crossref_primary_10_3389_fphar_2018_00625 crossref_primary_10_1021_acsnano_4c14698 crossref_primary_10_1155_2017_6847070 crossref_primary_10_1016_j_nutres_2020_09_008 crossref_primary_10_1016_j_bmc_2016_11_015 crossref_primary_10_3390_diagnostics14171841 crossref_primary_10_1002_cpdd_574 crossref_primary_10_1080_00325481_2019_1649975 crossref_primary_10_1016_j_msard_2021_102834 crossref_primary_10_1016_j_addr_2020_04_009 crossref_primary_10_22379_anc_v41i1_1862 crossref_primary_10_1007_s10072_025_08507_x crossref_primary_10_1016_j_jsbmb_2023_106425 crossref_primary_10_1016_j_msard_2020_102309 crossref_primary_10_1515_cclm_2017_0285 crossref_primary_10_1080_1028415X_2017_1371389 crossref_primary_10_3389_fpubh_2023_1073278 crossref_primary_10_3390_ijms24031861 crossref_primary_10_1016_j_banm_2025_07_002 crossref_primary_10_3390_ijms24021001 crossref_primary_10_1016_j_banm_2019_09_003 crossref_primary_10_1016_j_msard_2021_102963 crossref_primary_10_1016_j_clnu_2018_10_026 crossref_primary_10_1016_j_neuarg_2016_10_005 crossref_primary_10_1371_journal_pone_0231483 crossref_primary_10_3233_HAB_230010 crossref_primary_10_1007_s11030_021_10274_8 crossref_primary_10_3389_fneur_2023_1113954 crossref_primary_10_1016_j_msard_2025_106416 crossref_primary_10_1080_1028415X_2020_1758887 crossref_primary_10_1007_s12031_024_02301_8 crossref_primary_10_1093_geronb_gbw122 crossref_primary_10_1186_s12879_017_2319_7 crossref_primary_10_4103_1673_5374_262568 crossref_primary_10_1016_j_imlet_2017_02_003 crossref_primary_10_3390_brainsci13071073 crossref_primary_10_3389_fneur_2024_1386527 crossref_primary_10_17656_jsmc_10317 crossref_primary_10_1016_j_msard_2020_102339 crossref_primary_10_1080_09638288_2021_1960441 crossref_primary_10_31393_reports_vnmedical_2025_29_1__02 crossref_primary_10_1016_j_jaut_2018_10_006 crossref_primary_10_1016_j_neurol_2023_12_007 crossref_primary_10_1016_j_arth_2017_07_006 crossref_primary_10_1016_j_actpha_2025_01_007 crossref_primary_10_1016_j_ibneur_2022_10_015 crossref_primary_10_1038_s41409_021_01276_z crossref_primary_10_3389_fneur_2020_00642 crossref_primary_10_1093_arclin_acab066 crossref_primary_10_1186_s12911_022_02078_z crossref_primary_10_1515_revneuro_2018_0074 crossref_primary_10_1016_j_msard_2024_105832 crossref_primary_10_1177_08465371231180815 crossref_primary_10_36290_neu_2018_077 crossref_primary_10_3390_jpm12050677 crossref_primary_10_1007_s00420_020_01564_z crossref_primary_10_1016_j_msard_2021_102865 crossref_primary_10_26787_nydha_2686_6838_2025_27_9_66_71 crossref_primary_10_1016_j_clineuro_2020_106197 crossref_primary_10_1136_bmjopen_2018_024555 crossref_primary_10_3390_ijms242417243 crossref_primary_10_3389_fnins_2023_1308345 crossref_primary_10_1007_s12011_018_1380_4 crossref_primary_10_1186_s12883_022_02691_5 crossref_primary_10_3390_ctn9010016 crossref_primary_10_3390_medicina59061028 crossref_primary_10_3389_fnmol_2025_1567226 crossref_primary_10_1002_jcp_26000 crossref_primary_10_1016_j_isci_2025_113048 crossref_primary_10_1007_s10072_020_04842_3 crossref_primary_10_1002_ddr_70059 crossref_primary_10_3389_fnins_2020_00875 crossref_primary_10_1016_j_msard_2022_104416 crossref_primary_10_1016_j_heliyon_2024_e27304 crossref_primary_10_1111_ene_14764 crossref_primary_10_1097_01_NPR_0000000000000083 crossref_primary_10_1080_13543784_2025_2472240 crossref_primary_10_1155_2017_6198530 crossref_primary_10_7759_cureus_14383 crossref_primary_10_1002_sim_70037 crossref_primary_10_1007_s00415_017_8595_8 crossref_primary_10_1186_s12883_025_04054_2 crossref_primary_10_1177_13524585231223395 crossref_primary_10_1016_j_neuroscience_2022_03_031 crossref_primary_10_1016_j_msard_2018_06_014 crossref_primary_10_1080_1744666X_2021_1986005 crossref_primary_10_36290_neu_2019_134 crossref_primary_10_36290_neu_2022_059 crossref_primary_10_1186_s13023_016_0457_4 crossref_primary_10_1177_0030222819880714 crossref_primary_10_1016_j_msard_2022_103679 crossref_primary_10_1007_s10198_022_01471_9 crossref_primary_10_3390_jcm9051597 crossref_primary_10_34172_jcs_2021_015 crossref_primary_10_3390_jcm13010214 crossref_primary_10_1007_s11011_022_01083_5 crossref_primary_10_1089_brain_2020_0857 crossref_primary_10_4132_jptm_2025_05_20 crossref_primary_10_1016_j_jmir_2022_11_017 crossref_primary_10_1177_1352458516670738 crossref_primary_10_3389_fimmu_2022_902658 crossref_primary_10_1007_s10072_019_04234_2 crossref_primary_10_7759_cureus_22419 crossref_primary_10_1016_j_msard_2021_103108 crossref_primary_10_1007_s10926_022_10084_1 crossref_primary_10_3390_jcm13123604 crossref_primary_10_1007_s11682_022_00737_3 crossref_primary_10_1016_j_msard_2020_102416 crossref_primary_10_3390_ph16020311 crossref_primary_10_1016_j_clineuro_2017_10_004 crossref_primary_10_1111_pin_13270 crossref_primary_10_1016_j_msard_2025_106451 crossref_primary_10_1007_s10787_018_0531_8 crossref_primary_10_1111_pai_13093 crossref_primary_10_1016_j_msard_2019_03_022 crossref_primary_10_3390_brainsci10060338 crossref_primary_10_1016_j_msard_2018_12_025 crossref_primary_10_1542_peds_2025_070891 crossref_primary_10_1007_s12026_024_09471_y crossref_primary_10_1093_jsxmed_qdaf102 crossref_primary_10_3390_v16010119 crossref_primary_10_1212_NXI_0000000000000584 crossref_primary_10_1080_14760584_2016_1229602 crossref_primary_10_5812_ans_89632 crossref_primary_10_1007_s00062_018_0678_0 crossref_primary_10_1007_s12035_017_0530_6 crossref_primary_10_1007_s00213_025_06874_z crossref_primary_10_1016_j_msard_2020_102521 crossref_primary_10_4049_jimmunol_2100813 crossref_primary_10_3390_brainsci11101363 crossref_primary_10_1007_s12035_024_04270_w crossref_primary_10_1186_s12883_024_03777_y crossref_primary_10_1177_02692155221128723 crossref_primary_10_1111_ppc_12760 |
| Cites_doi | 10.1111/j.1600-0404.2010.01465.x 10.1177/1352458511421917 10.1136/jnnp.66.3.411 10.1093/brain/119.1.203 10.1136/jnnp.74.1.25 10.1212/WNL.38.3.416 10.1212/WNL.0b013e3181c1e44f 10.1016/j.respe.2009.08.012 10.1016/S0022-510X(03)00122-9 10.1007/s11481-010-9201-3 10.1111/j.1468-1331.2008.02241.x 10.1212/WNL.51.3.765 10.1111/j.1399-0039.1972.tb00111.x 10.1212/WNL.0b013e31821d74c5 10.1111/j.1399-0039.1991.tb02029.x 10.1212/WNL.42.5.991 10.1212/WNL.0b013e31829a3388 10.1177/1352458511421107 10.1038/nrneurol.2012.226 10.1093/brain/awh104 10.1016/j.lpm.2015.01.001 10.1177/1352458508093890 10.1093/brain/112.1.133 10.1159/000067107 10.1177/1352458508097919 10.1038/ng2103 10.1177/1352458509345909 10.1177/1352458514564489 10.1177/1352458509107010 10.1093/brain/awq134 10.1136/jnnp.2011.240432 10.1016/S1474-4422(14)70267-4 10.1371/journal.pone.0016149 10.1177/1352458515574896 10.1177/1352458510364197 10.1212/WNL.53.8.1711 10.1136/jnnp-2011-300616 10.1073/pnas.88.19.8480 10.1016/S1474-4422(06)70581-6 10.18553/jmcp.2008.14.S3-A.2 10.1007/s00415-006-0395-5 10.1093/brain/awq076 10.1111/j.1468-1331.2012.03668.x 10.1159/000081052 10.1016/S1474-4422(14)70041-9 10.1056/NEJMoa073493 10.1212/01.wnl.0000194259.90286.fe 10.1016/j.psc.2010.01.003 10.1177/1352458511433305 10.3810/pgm.2009.11.2074 10.1093/brain/awh721 10.1093/brain/awm329 10.1016/S1474-4422(10)70094-6 10.1111/j.1600-0404.2004.00326.x 10.1056/NEJM200011163432001 10.1177/1352458507077410 10.1212/01.wnl.0000210506.00078.5c 10.1159/000090444 10.1111/ane.12332 10.1073/pnas.1932604100 10.1177/1352458507077938 10.1212/WNL.58.1.136 10.1016/j.jns.2011.09.003 10.1111/ene.12586 10.1093/brain/awq118 10.1159/000341902 10.1093/brain/123.8.1677 10.1212/WNL.0b013e31820a0a9f 10.1212/WNL.0b013e318230a17d 10.1093/brain/awl007 10.1136/jnnp.50.5.523 10.1093/brain/116.1.117 10.1136/jnnp.2006.101196 10.1136/jnnp.2007.127332 10.1212/WNL.0b013e31825830a9 10.1093/brain/awg081 10.1111/j.1468-1331.2006.01342.x 10.1136/jnnp.55.8.671 10.1007/s00415-005-0934-5 10.1177/1352458511421106 10.1016/S1474-4422(10)70064-8 10.1586/14737175.2013.865866 10.1177/1352458511421105 10.1111/j.1468-1331.2007.02019.x 10.1177/1352458510379244 10.1093/brain/122.4.625 10.1371/journal.pone.0132033 |
| ContentType | Journal Article |
| Copyright | 2015 Elsevier Masson SAS Copyright © 2015 Elsevier Masson SAS. All rights reserved. licence_http://creativecommons.org/publicdomain/zero |
| Copyright_xml | – notice: 2015 Elsevier Masson SAS – notice: Copyright © 2015 Elsevier Masson SAS. All rights reserved. – notice: licence_http://creativecommons.org/publicdomain/zero |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC |
| DOI | 10.1016/j.neurol.2015.10.006 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EndPage | 13 |
| ExternalDocumentID | oai:HAL:hal-01255824v1 26718593 10_1016_j_neurol_2015_10_006 S0035378715009194 |
| Genre | Journal Article |
| GroupedDBID | --- --M 08J 08T 0R~ 123 4.4 457 53G 5RE AACTN AADPK AAEDT AAEDW AAFWJ AAIAV AAKOC AALRI AAOAW AAXLA AAXUO ABFNM ABIVO ABLVK ABMAC ABMZM ABYKQ ACDAQ ACRLP ADBBV AEBSH AENEX AFKWA AFTJW AFXIZ AGUBO AIEXJ AIKHN AITUG AJBFU ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BNPGV CS3 DU5 EBS EFJIC EFLBG EJD F5P FDB FIRID FYGXN HZ~ KOM O9- P2P ROL SEM SES SPCBC SSH SSN SSZ T5K ZGI ZXP ~G- AAQFI AATTM AAXKI AAYWO AAYXX ABJNI ACIEU ACLOT ACVFH ADCNI AEIPS AEUPX AFJKZ AFPUW AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP CITATION EFKBS CGR CUY CVF ECM EIF NPM 7X8 1XC |
| ID | FETCH-LOGICAL-c396t-fd92d9f2ad82a852c494fa79c2278ea75a50f8de36db5b121fe5287b8c8908e23 |
| ISICitedReferencesCount | 355 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000370466400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0035-3787 |
| IngestDate | Fri Nov 28 06:21:22 EST 2025 Sun Sep 28 03:12:07 EDT 2025 Wed Feb 19 02:00:28 EST 2025 Tue Nov 18 22:31:05 EST 2025 Sat Nov 29 01:48:46 EST 2025 Fri Feb 23 02:28:00 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Multiple sclerosis Prevalence Mortality Natural history Risk factors Incidence Multiple Sclerosis Risk Factors |
| Language | English |
| License | Copyright © 2015 Elsevier Masson SAS. All rights reserved. licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c396t-fd92d9f2ad82a852c494fa79c2278ea75a50f8de36db5b121fe5287b8c8908e23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-8424-4499 0009-0001-1130-7214 |
| PMID | 26718593 |
| PQID | 1760893034 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | hal_primary_oai_HAL_hal_01255824v1 proquest_miscellaneous_1760893034 pubmed_primary_26718593 crossref_primary_10_1016_j_neurol_2015_10_006 crossref_citationtrail_10_1016_j_neurol_2015_10_006 elsevier_sciencedirect_doi_10_1016_j_neurol_2015_10_006 |
| PublicationCentury | 2000 |
| PublicationDate | January 2016 2016-01-00 2016-Jan 20160101 2016-01 |
| PublicationDateYYYYMMDD | 2016-01-01 |
| PublicationDate_xml | – month: 01 year: 2016 text: January 2016 |
| PublicationDecade | 2010 |
| PublicationPlace | France |
| PublicationPlace_xml | – name: France |
| PublicationTitle | Revue neurologique |
| PublicationTitleAlternate | Rev Neurol (Paris) |
| PublicationYear | 2016 |
| Publisher | Elsevier Masson SAS Elsevier Masson |
| Publisher_xml | – name: Elsevier Masson SAS – name: Elsevier Masson |
| References | Pantazou, Schluep, Du Pasquier (bib0605) 2015; 44 McDonnell, Hawkins (bib0825) 1999; 66 Sumelahti, Tienari, Hakama, Wikstrom (bib0685) 2003; 74 Scalfari, Neuhaus, Daumer, Ebers, Muraro (bib0875) 2011; 77 Grytten Torkildsen, Lie, Aarseth, Nyland, Myhr (bib0515) 2008; 14 Scalfari, Neuhaus, Degenhardt, Rice, Muraro, Daumer (bib0870) 2010; 133 Handel, Williamson, Disanto, Dobson, Giovannoni, Ramagopalan (bib0590) 2011; 6 Redelings, McCoy, Sorvillo (bib0560) 2006; 26 Hutchinson (bib0775) 2011; 17 Noonan, Kathman, White (bib0830) 2002; 58 Beretich, Beretich (bib0750) 2009; 15 Wasay, Khatri, Khealani, Sheerani (bib0840) 2006; 13 Hafler, Compston, Sawcer, Lander, Daly, De Jager (bib0640) 2007; 357 Fromont, Binquet, Sauleau, Fournel, Despalins, Rollot (bib0725) 2012; 18 Risberg, Aarseth, Nyland, Lauer, Myhr, Midgard (bib0680) 2010; 124 Sadovnick, Ebers, Wilson, Paty (bib0480) 1992; 42 Barnett, Williams, Day, Macaskill, McLeod (bib0805) 2003; 213 Confavreux, Compston, Hommes, McDonald, Thompson (bib0910) 1992; 55 Ramagopalan, Dobson, Meier, Giovannoni (bib0570) 2010; 9 Kotzamani, Panou, Mastorodemos, Tzagournissakis, Nikolakaki, Spanaki (bib0855) 2012; 78 Owens (bib0810) 2008; 14 Leray, Vukusic, Debouverie, Clanet, Brochet, Seze (bib0540) 2015; 10 Bronnum-Hansen, Koch-Henriksen, Stenager (bib0505) 2004; 127 Fernandez, Fernandez, Guerrero, Leon, Lopez-Madrona, Alonso (bib0740) 2011; 18 Pi-Sunyer (bib0850) 2009; 121 Debouverie, Pittion-Vouyovitch, Louis, Roederer, Guillemin (bib0715) 2007; 13 Ragonese, Aridon, Salemi, D’Amelio, Savettieri (bib0550) 2008; 15 Olerup, Hillert (bib0630) 1991; 38 Leray, Yaouanq, Le Page, Coustans, Laplaud, Oger (bib0900) 2010; 133 Ascherio (bib0580) 2013; 13 Jersild, Dupont, Fog, Hansen, Nielsen, Thomsen (bib0625) 1973; 5 Gallou, Madigand, Masse, Morel, Oger, Sabouraud (bib0705) 1983; 12 Fawcett, Skegg (bib0765) 1988; 38 Simpson, Taylor, van der Mei (bib0940) 2015; 21 Azarbad, Gonder-Frederick (bib0845) 2010; 33 Olerup, Troye-Blomberg, Schreuder, Riley (bib0785) 1991; 88 Sagnes-Raffy, Gourraud, Hannon, Bourrel, Laffontan, Gaulene (bib0700) 2010; 58 Smestad, Sandvik, Celius (bib0520) 2009; 15 Weinshenker, Bass, Rice, Noseworthy, Carriere, Baskerville (bib0860) 1989; 112 Debouverie, Pittion-Vouyovitch, Louis, Guillemin (bib0905) 2008; 15 Marrie, Reider, Cohen, Stuve, Trojano, Sorensen (bib0545) 2015; 21 Debouverie, Laforest, Van Ganse, Guillemin (bib0920) 2009; 15 Kantarci, Siva, Eraksoy, Karabudak, Sutlas, Agaoglu (bib0490) 1998; 51 Midgard, Riise, Svanes, Kvale, Nyland (bib0800) 1996; 119 Li, Held, Petkau, Daumer, Barkhof, Fazekas (bib0925) 2006; 66 Fisniku, Brex, Altmann, Miszkiel, Benton, Lanyon (bib0930) 2008; 131 O’Gorman, Lin, Stankovich, Broadley (bib0615) 2012; 40 Sawcer (bib0635) 2011; 17 Orton, Wald, Confavreux, Vukusic, Krohn, Ramagopalan (bib0755) 2011; 76 Kremenchutzky, Rice, Baskerville, Wingerchuk, Ebers (bib0865) 2006; 129 Taithe, Tilignac, Rieu, Murat, Clavelou (bib0710) 2006; 12 Kingwell, van der Kop, Zhao, Shirani, Zhu, Oger (bib0535) 2011; 83 Taylor (bib0780) 2011; 17 Ascherio, Munger (bib0585) 2010; 5 Aladro, Alemany, Perez-Vieitez, Amela, Conde, Reyes (bib0675) 2005; 24 Debouverie, Vukusic, Ritleng, Laforest, Van Ganse, Confavreux (bib0790) 2008; 14 Confavreux, Vukusic, Moreau, Adeleine (bib0890) 2000; 343 Belbasis, Bellou, Evangelou, Ioannidis, Tzoulaki (bib0575) 2015; 14 Scalfari, Knappertz, Cutter, Goodin, Ashton, Ebers (bib0555) 2013; 81 Bentzen, Flachs, Stenager, Bronnum-Hansen, Koch-Henriksen (bib0665) 2010; 16 Bostrom, Callander, Kurtzke, Landtblom (bib0660) 2009; 15 Kampman, Wilsgaard, Mellgren (bib0760) 2007; 254 Orton, Herrera, Yee, Valdar, Ramagopalan, Sadovnick (bib0795) 2006; 5 Confavreux, Vukusic, Adeleine (bib0915) 2003; 126 Gregory, Schmidt, Seth, Oksenberg, Hart, Prokop (bib0645) 2007; 39 Hirst, Swingler, Compston, Ben-Shlomo, Robertson (bib0565) 2008; 79 Fromont, Binquet, Sauleau, Fournel, Bellisario, Adnet (bib0695) 2010; 133 Confavreux, Vukusic (bib0895) 2006; 129 Vukusic, Van Bockstael, Gosselin, Confavreux (bib0690) 2007; 78 Koch-Henriksen, Sorensen (bib0735) 2011; 311 Tremlett, Yousefi, Devonshire, Rieckmann, Zhao (bib0885) 2009; 73 Goulden, Ibrahim, Wolfson (bib0595) 2014; 22 Runmarker, Andersen (bib0485) 1993; 116 Willer, Dyment, Risch, Sadovnick, Ebers (bib0610) 2003; 100 Pugliatti, Rosati, Carton, Riise, Drulovic, Vecsei (bib0835) 2006; 13 Leray, Morrissey, Yaouanq, Coustans, Le Page, Chaperon (bib0510) 2007; 13 Naito, Namerow, Mickey, Terasaki (bib0620) 1972; 2 Koch, Metz, Kovalchuk (bib0655) 2012; 9 Riise, Mohr, Munger, Rich-Edwards, Kawachi, Ascherio (bib0600) 2011; 76 Phadke (bib0475) 1987; 50 Coles, Cox, Le Page, Jones, Trip, Deans (bib0935) 2006; 253 Koch-Henriksen, Sorensen (bib0730) 2010; 9 Tremlett, Paty, Devonshire (bib0880) 2006; 66 Wallin, Page, Kurtzke (bib0500) 2000; 123 Cottrell, Kremenchutzky, Rice, Koopman, Hader, Baskerville (bib0495) 1999; 122 Sawcer, Franklin, Ban (bib0650) 2014; 13 Krökki, Bloigu, Reunanen, Remes (bib0820) 2011; 17 Sarasoja, Wikstrom, Paltamaa, Hakama, Sumelahti (bib0670) 2004; 110 Yaouanq, Tron, Kerbrat, Leray, Hamonic, Merienne (bib0720) 2014; 131 Lalmohamed, Bazelier, Van Staa, Uitdehaag, Leufkens, De Boer (bib0530) 2012; 19 Zivadinov, Iona, Monti-Bragadin, Bosco, Jurjevic, Taus (bib0745) 2003; 22 Simpson, Blizzard, Otahal, Van der Mei, Taylor (bib0770) 2011; 82 Sumelahti, Hakama, Elovaara, Pukkala (bib0525) 2010; 16 Hernan, Olek, Ascherio (bib0815) 1999; 53 Olerup (10.1016/j.neurol.2015.10.006_bib0785) 1991; 88 Debouverie (10.1016/j.neurol.2015.10.006_bib0920) 2009; 15 Confavreux (10.1016/j.neurol.2015.10.006_bib0915) 2003; 126 Coles (10.1016/j.neurol.2015.10.006_bib0935) 2006; 253 Grytten Torkildsen (10.1016/j.neurol.2015.10.006_bib0515) 2008; 14 Bentzen (10.1016/j.neurol.2015.10.006_bib0665) 2010; 16 Leray (10.1016/j.neurol.2015.10.006_bib0900) 2010; 133 Debouverie (10.1016/j.neurol.2015.10.006_bib0905) 2008; 15 Pi-Sunyer (10.1016/j.neurol.2015.10.006_bib0850) 2009; 121 Scalfari (10.1016/j.neurol.2015.10.006_bib0875) 2011; 77 Ascherio (10.1016/j.neurol.2015.10.006_bib0580) 2013; 13 Riise (10.1016/j.neurol.2015.10.006_bib0600) 2011; 76 O’Gorman (10.1016/j.neurol.2015.10.006_bib0615) 2012; 40 Pantazou (10.1016/j.neurol.2015.10.006_bib0605) 2015; 44 Orton (10.1016/j.neurol.2015.10.006_bib0795) 2006; 5 Leray (10.1016/j.neurol.2015.10.006_bib0510) 2007; 13 Sumelahti (10.1016/j.neurol.2015.10.006_bib0685) 2003; 74 Azarbad (10.1016/j.neurol.2015.10.006_bib0845) 2010; 33 Marrie (10.1016/j.neurol.2015.10.006_bib0545) 2015; 21 Aladro (10.1016/j.neurol.2015.10.006_bib0675) 2005; 24 McDonnell (10.1016/j.neurol.2015.10.006_bib0825) 1999; 66 Sagnes-Raffy (10.1016/j.neurol.2015.10.006_bib0700) 2010; 58 Wallin (10.1016/j.neurol.2015.10.006_bib0500) 2000; 123 Naito (10.1016/j.neurol.2015.10.006_bib0620) 1972; 2 Ascherio (10.1016/j.neurol.2015.10.006_bib0585) 2010; 5 Owens (10.1016/j.neurol.2015.10.006_bib0810) 2008; 14 Confavreux (10.1016/j.neurol.2015.10.006_bib0910) 1992; 55 Fisniku (10.1016/j.neurol.2015.10.006_bib0930) 2008; 131 Ragonese (10.1016/j.neurol.2015.10.006_bib0550) 2008; 15 Kampman (10.1016/j.neurol.2015.10.006_bib0760) 2007; 254 Fromont (10.1016/j.neurol.2015.10.006_bib0695) 2010; 133 Cottrell (10.1016/j.neurol.2015.10.006_bib0495) 1999; 122 Leray (10.1016/j.neurol.2015.10.006_bib0540) 2015; 10 Gallou (10.1016/j.neurol.2015.10.006_bib0705) 1983; 12 Willer (10.1016/j.neurol.2015.10.006_bib0610) 2003; 100 Yaouanq (10.1016/j.neurol.2015.10.006_bib0720) 2014; 131 Noonan (10.1016/j.neurol.2015.10.006_bib0830) 2002; 58 Hernan (10.1016/j.neurol.2015.10.006_bib0815) 1999; 53 Goulden (10.1016/j.neurol.2015.10.006_bib0595) 2014; 22 Risberg (10.1016/j.neurol.2015.10.006_bib0680) 2010; 124 Orton (10.1016/j.neurol.2015.10.006_bib0755) 2011; 76 Barnett (10.1016/j.neurol.2015.10.006_bib0805) 2003; 213 Hutchinson (10.1016/j.neurol.2015.10.006_bib0775) 2011; 17 Gregory (10.1016/j.neurol.2015.10.006_bib0645) 2007; 39 Kotzamani (10.1016/j.neurol.2015.10.006_bib0855) 2012; 78 Simpson (10.1016/j.neurol.2015.10.006_bib0940) 2015; 21 Hafler (10.1016/j.neurol.2015.10.006_bib0640) 2007; 357 Fernandez (10.1016/j.neurol.2015.10.006_bib0740) 2011; 18 Bostrom (10.1016/j.neurol.2015.10.006_bib0660) 2009; 15 Debouverie (10.1016/j.neurol.2015.10.006_bib0715) 2007; 13 Midgard (10.1016/j.neurol.2015.10.006_bib0800) 1996; 119 Wasay (10.1016/j.neurol.2015.10.006_bib0840) 2006; 13 Sarasoja (10.1016/j.neurol.2015.10.006_bib0670) 2004; 110 Bronnum-Hansen (10.1016/j.neurol.2015.10.006_bib0505) 2004; 127 Jersild (10.1016/j.neurol.2015.10.006_bib0625) 1973; 5 Taylor (10.1016/j.neurol.2015.10.006_bib0780) 2011; 17 Kantarci (10.1016/j.neurol.2015.10.006_bib0490) 1998; 51 Olerup (10.1016/j.neurol.2015.10.006_bib0630) 1991; 38 Sawcer (10.1016/j.neurol.2015.10.006_bib0635) 2011; 17 Sumelahti (10.1016/j.neurol.2015.10.006_bib0525) 2010; 16 Koch-Henriksen (10.1016/j.neurol.2015.10.006_bib0730) 2010; 9 Vukusic (10.1016/j.neurol.2015.10.006_bib0690) 2007; 78 Ramagopalan (10.1016/j.neurol.2015.10.006_bib0570) 2010; 9 Weinshenker (10.1016/j.neurol.2015.10.006_bib0860) 1989; 112 Sadovnick (10.1016/j.neurol.2015.10.006_bib0480) 1992; 42 Koch (10.1016/j.neurol.2015.10.006_bib0655) 2012; 9 Handel (10.1016/j.neurol.2015.10.006_bib0590) 2011; 6 Li (10.1016/j.neurol.2015.10.006_bib0925) 2006; 66 Kingwell (10.1016/j.neurol.2015.10.006_bib0535) 2011; 83 Fromont (10.1016/j.neurol.2015.10.006_bib0725) 2012; 18 Confavreux (10.1016/j.neurol.2015.10.006_bib0890) 2000; 343 Belbasis (10.1016/j.neurol.2015.10.006_bib0575) 2015; 14 Debouverie (10.1016/j.neurol.2015.10.006_bib0790) 2008; 14 Beretich (10.1016/j.neurol.2015.10.006_bib0750) 2009; 15 Phadke (10.1016/j.neurol.2015.10.006_bib0475) 1987; 50 Redelings (10.1016/j.neurol.2015.10.006_bib0560) 2006; 26 Taithe (10.1016/j.neurol.2015.10.006_bib0710) 2006; 12 Simpson (10.1016/j.neurol.2015.10.006_bib0770) 2011; 82 Scalfari (10.1016/j.neurol.2015.10.006_bib0555) 2013; 81 Runmarker (10.1016/j.neurol.2015.10.006_bib0485) 1993; 116 Krökki (10.1016/j.neurol.2015.10.006_bib0820) 2011; 17 Hirst (10.1016/j.neurol.2015.10.006_bib0565) 2008; 79 Confavreux (10.1016/j.neurol.2015.10.006_bib0895) 2006; 129 Tremlett (10.1016/j.neurol.2015.10.006_bib0885) 2009; 73 Fawcett (10.1016/j.neurol.2015.10.006_bib0765) 1988; 38 Sawcer (10.1016/j.neurol.2015.10.006_bib0650) 2014; 13 Kremenchutzky (10.1016/j.neurol.2015.10.006_bib0865) 2006; 129 Scalfari (10.1016/j.neurol.2015.10.006_bib0870) 2010; 133 Koch-Henriksen (10.1016/j.neurol.2015.10.006_bib0735) 2011; 311 Smestad (10.1016/j.neurol.2015.10.006_bib0520) 2009; 15 Zivadinov (10.1016/j.neurol.2015.10.006_bib0745) 2003; 22 Tremlett (10.1016/j.neurol.2015.10.006_bib0880) 2006; 66 Pugliatti (10.1016/j.neurol.2015.10.006_bib0835) 2006; 13 Lalmohamed (10.1016/j.neurol.2015.10.006_bib0530) 2012; 19 |
| References_xml | – volume: 53 start-page: 1711 year: 1999 end-page: 1718 ident: bib0815 article-title: Geographic variation of MS incidence in two prospective studies of US women publication-title: Neurology – volume: 38 start-page: 1 year: 1991 end-page: 15 ident: bib0630 article-title: HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation publication-title: Tissue Antigens – volume: 13 start-page: 865 year: 2007 end-page: 874 ident: bib0510 article-title: Long-term survival of patients with multiple sclerosis in West France publication-title: Mult Scler – volume: 12 start-page: S132 year: 2006 ident: bib0710 article-title: Incidence of Multiple Sclerosis in Auvergne (French Country): a population-based study publication-title: Mult Scler – volume: 77 start-page: 1246 year: 2011 end-page: 1252 ident: bib0875 article-title: Age and disability accumulation in multiple sclerosis publication-title: Neurology – volume: 40 start-page: 1 year: 2012 end-page: 12 ident: bib0615 article-title: Modelling genetic susceptibility to multiple sclerosis with family data publication-title: Neuroepidemiology – volume: 76 start-page: 425 year: 2011 end-page: 431 ident: bib0755 article-title: Association of UV radiation with multiple sclerosis prevalence and sex ratio in France publication-title: Neurology – volume: 17 start-page: 1176 year: 2011 ident: bib0775 article-title: The major cause of multiple sclerosis is environmental: genetics has a minor role – commentary publication-title: Mult Scler – volume: 5 start-page: 932 year: 2006 end-page: 936 ident: bib0795 article-title: Sex ratio of multiple sclerosis in Canada: a longitudinal study publication-title: Lancet Neurol – volume: 100 start-page: 12877 year: 2003 end-page: 12882 ident: bib0610 article-title: Twin concordance and sibling recurrence rates in multiple sclerosis publication-title: Proc Natl Acad Sci U S A – volume: 26 start-page: 102 year: 2006 end-page: 107 ident: bib0560 article-title: Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001 publication-title: Neuroepidemiology – volume: 22 start-page: 899 year: 2014 end-page: 911 ident: bib0595 article-title: Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review publication-title: Eur J Neurol – volume: 44 start-page: e113 year: 2015 end-page: e120 ident: bib0605 article-title: Environmental factors in multiple sclerosis publication-title: Presse Med – volume: 42 start-page: 991 year: 1992 end-page: 994 ident: bib0480 article-title: Life expectancy in patients attending multiple sclerosis clinics publication-title: Neurology – volume: 66 start-page: 172 year: 2006 end-page: 177 ident: bib0880 article-title: Disability progression in multiple sclerosis is slower than previously reported publication-title: Neurology – volume: 10 start-page: e0132033 year: 2015 ident: bib0540 article-title: Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: data from a large-scale French observational study publication-title: PLoS One – volume: 311 start-page: 58 year: 2011 end-page: 63 ident: bib0735 article-title: Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere? publication-title: J Neurol Sci – volume: 73 start-page: 1616 year: 2009 end-page: 1623 ident: bib0885 article-title: Impact of multiple sclerosis relapses on progression diminishes with time publication-title: Neurology – volume: 133 start-page: 1889 year: 2010 end-page: 1899 ident: bib0695 article-title: Geographic variations of multiple sclerosis in France publication-title: Brain – volume: 9 start-page: 520 year: 2010 end-page: 532 ident: bib0730 article-title: The changing demographic pattern of multiple sclerosis epidemiology publication-title: Lancet Neurol – volume: 253 start-page: 98 year: 2006 end-page: 108 ident: bib0935 article-title: The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy publication-title: J Neurol – volume: 110 start-page: 331 year: 2004 end-page: 336 ident: bib0670 article-title: Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years publication-title: Acta Neurol Scand – volume: 122 start-page: 625 year: 1999 end-page: 639 ident: bib0495 article-title: The natural history of multiple sclerosis: a geographically based study 5. The clinical features and natural history of primary progressive multiple sclerosis publication-title: Brain – volume: 58 start-page: 23 year: 2010 end-page: 31 ident: bib0700 article-title: Multiple sclerosis in Haute-Garonne: an important underestimation of case numbers publication-title: Rev Epidemiol Sante Publique – volume: 131 start-page: 321 year: 2014 end-page: 328 ident: bib0720 article-title: Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000–2001 publication-title: Acta Neurol Scand – volume: 19 start-page: 1007 year: 2012 end-page: 1014 ident: bib0530 article-title: Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study publication-title: Eur J Neurol – volume: 22 start-page: 65 year: 2003 end-page: 74 ident: bib0745 article-title: The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study publication-title: Neuroepidemiology – volume: 50 start-page: 523 year: 1987 end-page: 531 ident: bib0475 article-title: Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in northeast Scotland publication-title: J Neurol Neurosurg Psychiatry – volume: 15 start-page: 1263 year: 2009 end-page: 1270 ident: bib0520 article-title: Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients publication-title: Mult Scler – volume: 13 start-page: 962 year: 2007 end-page: 967 ident: bib0715 article-title: Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France publication-title: Mult Scler – volume: 123 start-page: 1677 year: 2000 end-page: 1687 ident: bib0500 article-title: Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis publication-title: Brain – volume: 9 start-page: 727 year: 2010 end-page: 739 ident: bib0570 article-title: Multiple sclerosis: risk factors, prodromes, and potential causal pathways publication-title: Lancet Neurol – volume: 12 start-page: 995 year: 1983 end-page: 999 ident: bib0705 article-title: [Epidemiology of multiple sclerosis in Brittany] publication-title: Presse Med – volume: 15 start-page: 1253 year: 2009 end-page: 1262 ident: bib0660 article-title: High prevalence of multiple sclerosis in the Swedish county of Varmland publication-title: Mult Scler – volume: 5 start-page: 1791 year: 1973 end-page: 1796 ident: bib0625 article-title: Histocompatibility-linked immune-response determinants in multiple sclerosis publication-title: Transplant Proc – volume: 126 start-page: 770 year: 2003 end-page: 782 ident: bib0915 article-title: Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process publication-title: Brain – volume: 121 start-page: 21 year: 2009 end-page: 33 ident: bib0850 article-title: The medical risks of obesity publication-title: Postgrad Med – volume: 83 start-page: 61 year: 2011 end-page: 66 ident: bib0535 article-title: Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada publication-title: J Neurol Neurosurg Psychiatry – volume: 15 start-page: 251 year: 2009 end-page: 257 ident: bib0920 article-title: Earlier disability of the patients followed in multiple sclerosis centers compared to outpatients publication-title: Mult Scler – volume: 17 start-page: 133 year: 2011 end-page: 138 ident: bib0820 article-title: Increasing incidence of multiple sclerosis in Women in Northern Finland publication-title: Int MS J – volume: 14 start-page: 263 year: 2015 end-page: 273 ident: bib0575 article-title: Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses publication-title: Lancet Neurol – volume: 66 start-page: 1384 year: 2006 end-page: 1389 ident: bib0925 article-title: MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability publication-title: Neurology – volume: 17 start-page: 1171 year: 2011 end-page: 1173 ident: bib0780 article-title: The major cause of multiple sclerosis is environmental: genetics has a minor role–yes publication-title: Mult Scler – volume: 15 start-page: 916 year: 2008 end-page: 921 ident: bib0905 article-title: Natural history of multiple sclerosis in a population-based cohort publication-title: Eur J Neurol – volume: 13 start-page: 700 year: 2006 end-page: 722 ident: bib0835 article-title: The epidemiology of multiple sclerosis in Europe publication-title: Eur J Neurol – volume: 127 start-page: 844 year: 2004 end-page: 850 ident: bib0505 article-title: Trends in survival and cause of death in Danish patients with multiple sclerosis publication-title: Brain – volume: 79 start-page: 1016 year: 2008 end-page: 1021 ident: bib0565 article-title: Survival and cause of death in multiple sclerosis: a prospective population-based study publication-title: J Neurol Neurosurg Psychiatry – volume: 133 start-page: 1900 year: 2010 end-page: 1913 ident: bib0900 article-title: Evidence for a two-stage disability progression in multiple sclerosis publication-title: Brain – volume: 78 start-page: 707 year: 2007 end-page: 709 ident: bib0690 article-title: Regional variations in the prevalence of multiple sclerosis in French farmers publication-title: J Neurol Neurosurg Psychiatry – volume: 131 start-page: 808 year: 2008 end-page: 817 ident: bib0930 article-title: Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis publication-title: Brain – volume: 357 start-page: 851 year: 2007 end-page: 862 ident: bib0640 article-title: Risk alleles for multiple sclerosis identified by a genome-wide study publication-title: N Engl J Med – volume: 74 start-page: 25 year: 2003 end-page: 28 ident: bib0685 article-title: Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses publication-title: J Neurol Neurosurg Psychiatry – volume: 13 start-page: 3 year: 2013 end-page: 9 ident: bib0580 article-title: Environmental factors in multiple sclerosis publication-title: Expert Rev Neurother – volume: 5 start-page: 271 year: 2010 end-page: 277 ident: bib0585 article-title: Epstein-barr virus infection and multiple sclerosis: a review publication-title: J Neuroimmune Pharmacol – volume: 33 start-page: 423 year: 2010 end-page: 440 ident: bib0845 article-title: Obesity in women publication-title: Psychiatr Clin North Am – volume: 39 start-page: 1083 year: 2007 end-page: 1091 ident: bib0645 article-title: Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis publication-title: Nat Genet – volume: 119 start-page: 203 year: 1996 end-page: 211 ident: bib0800 article-title: Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis publication-title: Brain – volume: 112 start-page: 133 year: 1989 end-page: 146 ident: bib0860 article-title: The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability publication-title: Brain – volume: 133 start-page: 1914 year: 2010 end-page: 1929 ident: bib0870 article-title: The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability publication-title: Brain – volume: 66 start-page: 411 year: 1999 ident: bib0825 article-title: High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition publication-title: J Neurol Neurosurg Psychiatry – volume: 6 start-page: e16149 year: 2011 ident: bib0590 article-title: Smoking and multiple sclerosis: an updated meta-analysis publication-title: PLoS One – volume: 81 start-page: 184 year: 2013 end-page: 192 ident: bib0555 article-title: Mortality in patients with multiple sclerosis publication-title: Neurology – volume: 16 start-page: 520 year: 2010 end-page: 525 ident: bib0665 article-title: Prevalence of multiple sclerosis in Denmark 1950–2005 publication-title: Mult Scler – volume: 78 start-page: 1728 year: 2012 end-page: 1735 ident: bib0855 article-title: Rising incidence of multiple sclerosis in females associated with urbanization publication-title: Neurology – volume: 9 start-page: 35 year: 2012 end-page: 43 ident: bib0655 article-title: Epigenetic changes in patients with multiple sclerosis publication-title: Nat Rev Neurol – volume: 116 start-page: 117 year: 1993 end-page: 134 ident: bib0485 article-title: Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up publication-title: Brain – volume: 82 start-page: 1132 year: 2011 end-page: 1141 ident: bib0770 article-title: Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis publication-title: J Neurol Neurosurg Psychiatry – volume: 16 start-page: 1437 year: 2010 end-page: 1442 ident: bib0525 article-title: Causes of death among patients with multiple sclerosis publication-title: Mult Scler – volume: 213 start-page: 1 year: 2003 end-page: 6 ident: bib0805 article-title: Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study publication-title: J Neurol Sci – volume: 24 start-page: 70 year: 2005 end-page: 75 ident: bib0675 article-title: Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain publication-title: Neuroepidemiology – volume: 129 start-page: 606 year: 2006 end-page: 616 ident: bib0895 article-title: Natural history of multiple sclerosis: a unifying concept publication-title: Brain – volume: 2 start-page: 1 year: 1972 end-page: 4 ident: bib0620 article-title: Multiple sclerosis: association with HL-A3 publication-title: Tissue Antigens – volume: 18 start-page: 1108 year: 2012 end-page: 1115 ident: bib0725 article-title: National estimate of multiple sclerosis incidence in France (2001–2007) publication-title: Mult Scler – volume: 76 start-page: 1866 year: 2011 end-page: 1871 ident: bib0600 article-title: Stress and the risk of multiple sclerosis publication-title: Neurology – volume: 88 start-page: 8480 year: 1991 end-page: 8484 ident: bib0785 article-title: HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications publication-title: Proc Natl Acad Sci U S A – volume: 38 start-page: 416 year: 1988 end-page: 418 ident: bib0765 article-title: Geographic distribution of MS in New Zealand: evidence from hospital admissions and deaths publication-title: Neurology – volume: 15 start-page: 123 year: 2008 end-page: 127 ident: bib0550 article-title: Mortality in multiple sclerosis: a review publication-title: Eur J Neurol – volume: 343 start-page: 1430 year: 2000 end-page: 1438 ident: bib0890 article-title: Relapses and progression of disability in multiple sclerosis publication-title: N Engl J Med – volume: 15 start-page: 891 year: 2009 end-page: 898 ident: bib0750 article-title: Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis publication-title: Int MS J – volume: 14 start-page: 2 year: 2008 end-page: 6 ident: bib0810 article-title: Gender differences in health care expanditures, resource utilization, and quality of care publication-title: J Manag Care Pharm – volume: 14 start-page: P116 year: 2008 ident: bib0790 article-title: Change of demographic data over time in Multiple Sclerosis. The Lyon multiple sclerosis cohort experience: Part I: sex ratio publication-title: Mult Scler – volume: 58 start-page: 136 year: 2002 end-page: 138 ident: bib0830 article-title: Prevalence estimates for MS in the United States and evidence of an increasing trend for women publication-title: Neurology – volume: 14 start-page: 1191 year: 2008 end-page: 1198 ident: bib0515 article-title: Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway publication-title: Mult Scler – volume: 17 start-page: 1174 year: 2011 end-page: 1175 ident: bib0635 article-title: The major cause of multiple sclerosis is environmental: genetics has a minor role – no publication-title: Mult Scler – volume: 254 start-page: 471 year: 2007 end-page: 477 ident: bib0760 article-title: Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle publication-title: J Neurol – volume: 124 start-page: 250 year: 2010 end-page: 257 ident: bib0680 article-title: Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway publication-title: Acta Neurol Scand – volume: 18 start-page: 372 year: 2011 end-page: 376 ident: bib0740 article-title: Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture-recapture method publication-title: Mult Scler – volume: 129 start-page: 584 year: 2006 end-page: 594 ident: bib0865 article-title: The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease publication-title: Brain – volume: 21 start-page: 294 year: 2015 end-page: 304 ident: bib0545 article-title: A systematic review of the incidence and prevalence of cancer in multiple sclerosis publication-title: Mult Scler – volume: 21 start-page: 969 year: 2015 end-page: 977 ident: bib0940 article-title: The role of epidemiology in MS research: past successes, current challenges and future potential publication-title: Mult Scler – volume: 55 start-page: 671 year: 1992 end-page: 676 ident: bib0910 article-title: EDMUS, a European database for multiple sclerosis publication-title: J Neurol Neurosurg Psychiatry – volume: 51 start-page: 765 year: 1998 end-page: 772 ident: bib0490 article-title: Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG) publication-title: Neurology – volume: 13 start-page: 58 year: 2006 end-page: 65 ident: bib0840 article-title: MS in Asian countries publication-title: Int MS J – volume: 13 start-page: 700 year: 2014 end-page: 709 ident: bib0650 article-title: Multiple sclerosis genetics publication-title: Lancet Neurol – volume: 124 start-page: 250 issue: 4 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0680 article-title: Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway publication-title: Acta Neurol Scand doi: 10.1111/j.1600-0404.2010.01465.x – volume: 18 start-page: 372 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0740 article-title: Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture-recapture method publication-title: Mult Scler doi: 10.1177/1352458511421917 – volume: 66 start-page: 411 issue: 3 year: 1999 ident: 10.1016/j.neurol.2015.10.006_bib0825 article-title: High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.66.3.411 – volume: 119 start-page: 203 year: 1996 ident: 10.1016/j.neurol.2015.10.006_bib0800 article-title: Incidence of multiple sclerosis in More and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis publication-title: Brain doi: 10.1093/brain/119.1.203 – volume: 74 start-page: 25 issue: 1 year: 2003 ident: 10.1016/j.neurol.2015.10.006_bib0685 article-title: Multiple sclerosis in Finland: incidence trends and differences in relapsing remitting and primary progressive disease courses publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.74.1.25 – volume: 12 start-page: 995 issue: 16 year: 1983 ident: 10.1016/j.neurol.2015.10.006_bib0705 article-title: [Epidemiology of multiple sclerosis in Brittany] publication-title: Presse Med – volume: 38 start-page: 416 issue: 3 year: 1988 ident: 10.1016/j.neurol.2015.10.006_bib0765 article-title: Geographic distribution of MS in New Zealand: evidence from hospital admissions and deaths publication-title: Neurology doi: 10.1212/WNL.38.3.416 – volume: 73 start-page: 1616 issue: 20 year: 2009 ident: 10.1016/j.neurol.2015.10.006_bib0885 article-title: Impact of multiple sclerosis relapses on progression diminishes with time publication-title: Neurology doi: 10.1212/WNL.0b013e3181c1e44f – volume: 58 start-page: 23 issue: 1 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0700 article-title: Multiple sclerosis in Haute-Garonne: an important underestimation of case numbers publication-title: Rev Epidemiol Sante Publique doi: 10.1016/j.respe.2009.08.012 – volume: 213 start-page: 1 issue: 1–2 year: 2003 ident: 10.1016/j.neurol.2015.10.006_bib0805 article-title: Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study publication-title: J Neurol Sci doi: 10.1016/S0022-510X(03)00122-9 – volume: 5 start-page: 271 issue: 3 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0585 article-title: Epstein-barr virus infection and multiple sclerosis: a review publication-title: J Neuroimmune Pharmacol doi: 10.1007/s11481-010-9201-3 – volume: 15 start-page: 916 issue: 9 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0905 article-title: Natural history of multiple sclerosis in a population-based cohort publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2008.02241.x – volume: 51 start-page: 765 issue: 3 year: 1998 ident: 10.1016/j.neurol.2015.10.006_bib0490 article-title: Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG) publication-title: Neurology doi: 10.1212/WNL.51.3.765 – volume: 2 start-page: 1 issue: 1 year: 1972 ident: 10.1016/j.neurol.2015.10.006_bib0620 article-title: Multiple sclerosis: association with HL-A3 publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.1972.tb00111.x – volume: 76 start-page: 1866 issue: 22 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0600 article-title: Stress and the risk of multiple sclerosis publication-title: Neurology doi: 10.1212/WNL.0b013e31821d74c5 – volume: 5 start-page: 1791 issue: 4 year: 1973 ident: 10.1016/j.neurol.2015.10.006_bib0625 article-title: Histocompatibility-linked immune-response determinants in multiple sclerosis publication-title: Transplant Proc – volume: 38 start-page: 1 issue: 1 year: 1991 ident: 10.1016/j.neurol.2015.10.006_bib0630 article-title: HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.1991.tb02029.x – volume: 42 start-page: 991 issue: 5 year: 1992 ident: 10.1016/j.neurol.2015.10.006_bib0480 article-title: Life expectancy in patients attending multiple sclerosis clinics publication-title: Neurology doi: 10.1212/WNL.42.5.991 – volume: 81 start-page: 184 issue: 2 year: 2013 ident: 10.1016/j.neurol.2015.10.006_bib0555 article-title: Mortality in patients with multiple sclerosis publication-title: Neurology doi: 10.1212/WNL.0b013e31829a3388 – volume: 17 start-page: 1176 issue: 10 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0775 article-title: The major cause of multiple sclerosis is environmental: genetics has a minor role – commentary publication-title: Mult Scler doi: 10.1177/1352458511421107 – volume: 9 start-page: 35 issue: 1 year: 2012 ident: 10.1016/j.neurol.2015.10.006_bib0655 article-title: Epigenetic changes in patients with multiple sclerosis publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2012.226 – volume: 127 start-page: 844 issue: Pt 4 year: 2004 ident: 10.1016/j.neurol.2015.10.006_bib0505 article-title: Trends in survival and cause of death in Danish patients with multiple sclerosis publication-title: Brain doi: 10.1093/brain/awh104 – volume: 44 start-page: e113 issue: 4 Pt 2 year: 2015 ident: 10.1016/j.neurol.2015.10.006_bib0605 article-title: Environmental factors in multiple sclerosis publication-title: Presse Med doi: 10.1016/j.lpm.2015.01.001 – volume: 14 start-page: 1191 issue: 9 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0515 article-title: Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway publication-title: Mult Scler doi: 10.1177/1352458508093890 – volume: 112 start-page: 133 issue: Pt 1 year: 1989 ident: 10.1016/j.neurol.2015.10.006_bib0860 article-title: The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability publication-title: Brain doi: 10.1093/brain/112.1.133 – volume: 22 start-page: 65 issue: 1 year: 2003 ident: 10.1016/j.neurol.2015.10.006_bib0745 article-title: The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study publication-title: Neuroepidemiology doi: 10.1159/000067107 – volume: 15 start-page: 251 issue: 2 year: 2009 ident: 10.1016/j.neurol.2015.10.006_bib0920 article-title: Earlier disability of the patients followed in multiple sclerosis centers compared to outpatients publication-title: Mult Scler doi: 10.1177/1352458508097919 – volume: 39 start-page: 1083 issue: 9 year: 2007 ident: 10.1016/j.neurol.2015.10.006_bib0645 article-title: Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis publication-title: Nat Genet doi: 10.1038/ng2103 – volume: 15 start-page: 1253 issue: 11 year: 2009 ident: 10.1016/j.neurol.2015.10.006_bib0660 article-title: High prevalence of multiple sclerosis in the Swedish county of Varmland publication-title: Mult Scler doi: 10.1177/1352458509345909 – volume: 21 start-page: 294 issue: 3 year: 2015 ident: 10.1016/j.neurol.2015.10.006_bib0545 article-title: A systematic review of the incidence and prevalence of cancer in multiple sclerosis publication-title: Mult Scler doi: 10.1177/1352458514564489 – volume: 15 start-page: 1263 issue: 11 year: 2009 ident: 10.1016/j.neurol.2015.10.006_bib0520 article-title: Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients publication-title: Mult Scler doi: 10.1177/1352458509107010 – volume: 133 start-page: 1889 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0695 article-title: Geographic variations of multiple sclerosis in France publication-title: Brain doi: 10.1093/brain/awq134 – volume: 82 start-page: 1132 issue: 10 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0770 article-title: Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2011.240432 – volume: 14 start-page: 263 issue: 3 year: 2015 ident: 10.1016/j.neurol.2015.10.006_bib0575 article-title: Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses publication-title: Lancet Neurol doi: 10.1016/S1474-4422(14)70267-4 – volume: 6 start-page: e16149 issue: 1 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0590 article-title: Smoking and multiple sclerosis: an updated meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0016149 – volume: 21 start-page: 969 issue: 8 year: 2015 ident: 10.1016/j.neurol.2015.10.006_bib0940 article-title: The role of epidemiology in MS research: past successes, current challenges and future potential publication-title: Mult Scler doi: 10.1177/1352458515574896 – volume: 16 start-page: 520 issue: 5 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0665 article-title: Prevalence of multiple sclerosis in Denmark 1950–2005 publication-title: Mult Scler doi: 10.1177/1352458510364197 – volume: 53 start-page: 1711 issue: 8 year: 1999 ident: 10.1016/j.neurol.2015.10.006_bib0815 article-title: Geographic variation of MS incidence in two prospective studies of US women publication-title: Neurology doi: 10.1212/WNL.53.8.1711 – volume: 83 start-page: 61 issue: 1 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0535 article-title: Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2011-300616 – volume: 88 start-page: 8480 issue: 19 year: 1991 ident: 10.1016/j.neurol.2015.10.006_bib0785 article-title: HLA-DR and -DQ gene polymorphism in West Africans is twice as extensive as in north European Caucasians: evolutionary implications publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.88.19.8480 – volume: 5 start-page: 932 issue: 11 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0795 article-title: Sex ratio of multiple sclerosis in Canada: a longitudinal study publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70581-6 – volume: 14 start-page: 2 issue: 3 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0810 article-title: Gender differences in health care expanditures, resource utilization, and quality of care publication-title: J Manag Care Pharm doi: 10.18553/jmcp.2008.14.S3-A.2 – volume: 254 start-page: 471 issue: 4 year: 2007 ident: 10.1016/j.neurol.2015.10.006_bib0760 article-title: Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle publication-title: J Neurol doi: 10.1007/s00415-006-0395-5 – volume: 133 start-page: 1900 issue: Pt 7 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0900 article-title: Evidence for a two-stage disability progression in multiple sclerosis publication-title: Brain doi: 10.1093/brain/awq076 – volume: 19 start-page: 1007 issue: 7 year: 2012 ident: 10.1016/j.neurol.2015.10.006_bib0530 article-title: Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2012.03668.x – volume: 24 start-page: 70 issue: 1–2 year: 2005 ident: 10.1016/j.neurol.2015.10.006_bib0675 article-title: Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain publication-title: Neuroepidemiology doi: 10.1159/000081052 – volume: 13 start-page: 700 issue: 7 year: 2014 ident: 10.1016/j.neurol.2015.10.006_bib0650 article-title: Multiple sclerosis genetics publication-title: Lancet Neurol doi: 10.1016/S1474-4422(14)70041-9 – volume: 357 start-page: 851 issue: 9 year: 2007 ident: 10.1016/j.neurol.2015.10.006_bib0640 article-title: Risk alleles for multiple sclerosis identified by a genome-wide study publication-title: N Engl J Med doi: 10.1056/NEJMoa073493 – volume: 66 start-page: 172 issue: 2 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0880 article-title: Disability progression in multiple sclerosis is slower than previously reported publication-title: Neurology doi: 10.1212/01.wnl.0000194259.90286.fe – volume: 33 start-page: 423 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0845 article-title: Obesity in women publication-title: Psychiatr Clin North Am doi: 10.1016/j.psc.2010.01.003 – volume: 18 start-page: 1108 year: 2012 ident: 10.1016/j.neurol.2015.10.006_bib0725 article-title: National estimate of multiple sclerosis incidence in France (2001–2007) publication-title: Mult Scler doi: 10.1177/1352458511433305 – volume: 121 start-page: 21 year: 2009 ident: 10.1016/j.neurol.2015.10.006_bib0850 article-title: The medical risks of obesity publication-title: Postgrad Med doi: 10.3810/pgm.2009.11.2074 – volume: 129 start-page: 584 issue: Pt 3 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0865 article-title: The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease publication-title: Brain doi: 10.1093/brain/awh721 – volume: 131 start-page: 808 issue: Pt 3 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0930 article-title: Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis publication-title: Brain doi: 10.1093/brain/awm329 – volume: 9 start-page: 727 issue: 7 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0570 article-title: Multiple sclerosis: risk factors, prodromes, and potential causal pathways publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70094-6 – volume: 13 start-page: 58 issue: 2 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0840 article-title: MS in Asian countries publication-title: Int MS J – volume: 110 start-page: 331 issue: 5 year: 2004 ident: 10.1016/j.neurol.2015.10.006_bib0670 article-title: Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years publication-title: Acta Neurol Scand doi: 10.1111/j.1600-0404.2004.00326.x – volume: 343 start-page: 1430 issue: 20 year: 2000 ident: 10.1016/j.neurol.2015.10.006_bib0890 article-title: Relapses and progression of disability in multiple sclerosis publication-title: N Engl J Med doi: 10.1056/NEJM200011163432001 – volume: 13 start-page: 865 issue: 7 year: 2007 ident: 10.1016/j.neurol.2015.10.006_bib0510 article-title: Long-term survival of patients with multiple sclerosis in West France publication-title: Mult Scler doi: 10.1177/1352458507077410 – volume: 66 start-page: 1384 issue: 9 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0925 article-title: MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability publication-title: Neurology doi: 10.1212/01.wnl.0000210506.00078.5c – volume: 12 start-page: S132 issue: Suppl. 1 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0710 article-title: Incidence of Multiple Sclerosis in Auvergne (French Country): a population-based study publication-title: Mult Scler – volume: 26 start-page: 102 issue: 2 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0560 article-title: Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001 publication-title: Neuroepidemiology doi: 10.1159/000090444 – volume: 131 start-page: 321 issue: 5 year: 2014 ident: 10.1016/j.neurol.2015.10.006_bib0720 article-title: Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000–2001 publication-title: Acta Neurol Scand doi: 10.1111/ane.12332 – volume: 100 start-page: 12877 issue: 22 year: 2003 ident: 10.1016/j.neurol.2015.10.006_bib0610 article-title: Twin concordance and sibling recurrence rates in multiple sclerosis publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1932604100 – volume: 13 start-page: 962 issue: 8 year: 2007 ident: 10.1016/j.neurol.2015.10.006_bib0715 article-title: Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France publication-title: Mult Scler doi: 10.1177/1352458507077938 – volume: 58 start-page: 136 issue: 1 year: 2002 ident: 10.1016/j.neurol.2015.10.006_bib0830 article-title: Prevalence estimates for MS in the United States and evidence of an increasing trend for women publication-title: Neurology doi: 10.1212/WNL.58.1.136 – volume: 311 start-page: 58 issue: 1–2 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0735 article-title: Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere? publication-title: J Neurol Sci doi: 10.1016/j.jns.2011.09.003 – volume: 22 start-page: 899 issue: 6 year: 2014 ident: 10.1016/j.neurol.2015.10.006_bib0595 article-title: Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review publication-title: Eur J Neurol doi: 10.1111/ene.12586 – volume: 133 start-page: 1914 issue: Pt 7 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0870 article-title: The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability publication-title: Brain doi: 10.1093/brain/awq118 – volume: 40 start-page: 1 issue: 1 year: 2012 ident: 10.1016/j.neurol.2015.10.006_bib0615 article-title: Modelling genetic susceptibility to multiple sclerosis with family data publication-title: Neuroepidemiology doi: 10.1159/000341902 – volume: 123 start-page: 1677 issue: Pt 8 year: 2000 ident: 10.1016/j.neurol.2015.10.006_bib0500 article-title: Epidemiology of multiple sclerosis in US veterans. VIII. Long-term survival after onset of multiple sclerosis publication-title: Brain doi: 10.1093/brain/123.8.1677 – volume: 76 start-page: 425 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0755 article-title: Association of UV radiation with multiple sclerosis prevalence and sex ratio in France publication-title: Neurology doi: 10.1212/WNL.0b013e31820a0a9f – volume: 17 start-page: 133 issue: 2 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0820 article-title: Increasing incidence of multiple sclerosis in Women in Northern Finland publication-title: Int MS J – volume: 77 start-page: 1246 issue: 13 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0875 article-title: Age and disability accumulation in multiple sclerosis publication-title: Neurology doi: 10.1212/WNL.0b013e318230a17d – volume: 129 start-page: 606 issue: Pt 3 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0895 article-title: Natural history of multiple sclerosis: a unifying concept publication-title: Brain doi: 10.1093/brain/awl007 – volume: 50 start-page: 523 issue: 5 year: 1987 ident: 10.1016/j.neurol.2015.10.006_bib0475 article-title: Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in northeast Scotland publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.50.5.523 – volume: 116 start-page: 117 issue: Pt 1 year: 1993 ident: 10.1016/j.neurol.2015.10.006_bib0485 article-title: Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up publication-title: Brain doi: 10.1093/brain/116.1.117 – volume: 78 start-page: 707 issue: 7 year: 2007 ident: 10.1016/j.neurol.2015.10.006_bib0690 article-title: Regional variations in the prevalence of multiple sclerosis in French farmers publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2006.101196 – volume: 79 start-page: 1016 issue: 9 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0565 article-title: Survival and cause of death in multiple sclerosis: a prospective population-based study publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.2007.127332 – volume: 78 start-page: 1728 issue: 22 year: 2012 ident: 10.1016/j.neurol.2015.10.006_bib0855 article-title: Rising incidence of multiple sclerosis in females associated with urbanization publication-title: Neurology doi: 10.1212/WNL.0b013e31825830a9 – volume: 126 start-page: 770 issue: Pt 4 year: 2003 ident: 10.1016/j.neurol.2015.10.006_bib0915 article-title: Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process publication-title: Brain doi: 10.1093/brain/awg081 – volume: 13 start-page: 700 issue: 7 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0835 article-title: The epidemiology of multiple sclerosis in Europe publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2006.01342.x – volume: 14 start-page: P116 issue: Suppl. 1 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0790 article-title: Change of demographic data over time in Multiple Sclerosis. The Lyon multiple sclerosis cohort experience: Part I: sex ratio publication-title: Mult Scler – volume: 55 start-page: 671 issue: 8 year: 1992 ident: 10.1016/j.neurol.2015.10.006_bib0910 article-title: EDMUS, a European database for multiple sclerosis publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.55.8.671 – volume: 253 start-page: 98 issue: 1 year: 2006 ident: 10.1016/j.neurol.2015.10.006_bib0935 article-title: The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy publication-title: J Neurol doi: 10.1007/s00415-005-0934-5 – volume: 17 start-page: 1174 issue: 10 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0635 article-title: The major cause of multiple sclerosis is environmental: genetics has a minor role – no publication-title: Mult Scler doi: 10.1177/1352458511421106 – volume: 9 start-page: 520 issue: 5 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0730 article-title: The changing demographic pattern of multiple sclerosis epidemiology publication-title: Lancet Neurol doi: 10.1016/S1474-4422(10)70064-8 – volume: 15 start-page: 891 issue: 8 year: 2009 ident: 10.1016/j.neurol.2015.10.006_bib0750 article-title: Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis publication-title: Int MS J – volume: 13 start-page: 3 issue: 12 Suppl. year: 2013 ident: 10.1016/j.neurol.2015.10.006_bib0580 article-title: Environmental factors in multiple sclerosis publication-title: Expert Rev Neurother doi: 10.1586/14737175.2013.865866 – volume: 17 start-page: 1171 issue: 10 year: 2011 ident: 10.1016/j.neurol.2015.10.006_bib0780 article-title: The major cause of multiple sclerosis is environmental: genetics has a minor role–yes publication-title: Mult Scler doi: 10.1177/1352458511421105 – volume: 15 start-page: 123 issue: 2 year: 2008 ident: 10.1016/j.neurol.2015.10.006_bib0550 article-title: Mortality in multiple sclerosis: a review publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2007.02019.x – volume: 16 start-page: 1437 issue: 12 year: 2010 ident: 10.1016/j.neurol.2015.10.006_bib0525 article-title: Causes of death among patients with multiple sclerosis publication-title: Mult Scler doi: 10.1177/1352458510379244 – volume: 122 start-page: 625 issue: Pt 4 year: 1999 ident: 10.1016/j.neurol.2015.10.006_bib0495 article-title: The natural history of multiple sclerosis: a geographically based study 5. The clinical features and natural history of primary progressive multiple sclerosis publication-title: Brain doi: 10.1093/brain/122.4.625 – volume: 10 start-page: e0132033 issue: 7 year: 2015 ident: 10.1016/j.neurol.2015.10.006_bib0540 article-title: Excess mortality in patients with multiple sclerosis starts at 20 years from clinical onset: data from a large-scale French observational study publication-title: PLoS One doi: 10.1371/journal.pone.0132033 |
| SSID | ssj0021703 |
| Score | 2.5472922 |
| Snippet | Multiple sclerosis (MS) is the most frequently seen demyelinating disease, with a prevalence that varies considerably, from high levels in North America and... |
| SourceID | hal proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3 |
| SubjectTerms | Disease Progression Female Humans Incidence Life Sciences Male Mortality Multiple sclerosis Multiple Sclerosis - diagnosis Multiple Sclerosis - epidemiology Natural history Prevalence Risk Factors |
| Title | Epidemiology of multiple sclerosis |
| URI | https://dx.doi.org/10.1016/j.neurol.2015.10.006 https://www.ncbi.nlm.nih.gov/pubmed/26718593 https://www.proquest.com/docview/1760893034 https://univ-rennes.hal.science/hal-01255824 |
| Volume | 172 |
| WOSCitedRecordID | wos000370466400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 issn: 0035-3787 databaseCode: AIEXJ dateStart: 20040601 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.sciencedirect.com omitProxy: false ssIdentifier: ssj0021703 providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZLO0Zfxu7LLsUrexsO1s2SHsNw1422jLUbeTOyLLOW4ZQ4Cf35PbJsxSyUboO9mHCwLEff8dEn6dMRQu9TzXhSqCIG7iBiRoiJNStYrBjWkhqp0na54MexOD2Vs5n62h2r2LTHCYi6ltfX6uq_Qg02ANttnf0LuMNDwQC_AXS4Auxw_SPgs82Zr371vJcMNnAj9IkXzZCQfrPrlf3QZrV0UdBLsDuJzkK3CGSTgMocKOaqhTjYDp2er0teEIxZ6edVP02Gswr491mFsN3lBCi8C1zTs2EUpRwCU9dR9lFUkC138TGRDjpXv-90K2z7GYTLif-3TnDHJ15zt-mmgnjwzNXvqgcuC2xHsRHaJYIriGm708_Z7EsYcGOR0D4tpyvQb51s9X3bdd1GTUY_nUb2tgFIS0TOH6GH3QgimnrkH6N7tn6CHpx0Gomn6GDoANG8inoHiIIDPEPfD7Pzj0dxdxJGbKhKl3FVKlKqiuhSEi05MUyxSgtl3EZmqwXXPKlkaWlaFrzABFeWw1C4kPCxJdIS-hzt1PPavkRRAUMAbEpthaFMYwNPAUpvhOGFLLFSY0T7RshNlybenVbyK-_1gJe5b7rcNZ2zQtONURxKXfk0KXfcL_r2zTuq5ylcDi5xR8kDgCNU4rKjH02Pc2cDrsW5JGyNx-hdj1YO4dKtgenazldNjkWaAEVPKBujFx7G8CySAlHjir7655d7jfY2H9MbtLNcrOxbdN-slxfNYh-NxEzud056A5TZlu0 |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+multiple+sclerosis&rft.jtitle=Revue+neurologique&rft.au=Leray%2C+E.&rft.au=Moreau%2C+T.&rft.au=Fromont%2C+A.&rft.au=Edan%2C+G.&rft.date=2016-01-01&rft.pub=Elsevier+Masson+SAS&rft.issn=0035-3787&rft.volume=172&rft.issue=1&rft.spage=3&rft.epage=13&rft_id=info:doi/10.1016%2Fj.neurol.2015.10.006&rft.externalDocID=S0035378715009194 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0035-3787&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0035-3787&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0035-3787&client=summon |